Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use

Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use

US Patent 12053466 · Granted Aug 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating multiple myeloma and the use of companion biomarkers for 4-2025
Antiproliferative compounds and second active agents for combined use2025
Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-ox2024
Methods of assessing suitability of use of pharmaceutical compositions of albumi2024
Antiproliferative compounds and methods of use thereof2024
Antiproliferative compounds and methods of use thereof2024
Methods for treating multiple myeloma and the use of companion biomarkers for 4-2023
Antiproliferative compounds and second active agents for combined use2023
Antiproliferative compounds and bispecific antibody against BCMA and CD3 for com2022
Antiproliferative compounds and bispecific antibody against BCMA and CD3 for com2022
Methods of assessing suitability of use of pharmaceutical compositions of albumi2022
Antiproliferative compounds and methods of use thereof2021